Announced Wed, 28 Oct, 2026 · 19:09 IST
Remus Pharma schedules H1 FY2027 earnings call for November 4, 2026
REMUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reactionminutes from the announcement price · days from the prior close
-0.5%Reaction day
₹879.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
-0.5pendingpending
Next day
———
2d
———
3d
———
4d
———
5d
———
1w
———
15d
———
1m
———
2m
———
3m
———
UpDownMarket · Nifty Microcap 250Pending
Minute windows have no benchmark: there is no intraday index history to compare against.
AI summary
Remus Pharmaceuticals will hold an earnings call at noon IST on November 4, 2026, after announcing unaudited standalone and consolidated results for the half year ended September 30, 2026. The managing director and chief financial officer will attend. An audio recording and transcript will later be posted on the company website.
Likely market impact
This is a routine scheduling notice. No financial results, business updates or trading details were disclosed.